awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34405616-9940A212-6CB9-4DBD-9BD1-C111037377E4
Q34405616-9940A212-6CB9-4DBD-9BD1-C111037377E4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34405616-9940A212-6CB9-4DBD-9BD1-C111037377E4
Anti-CD40-mediated cancer immunotherapy: an update of recent and ongoing clinical trials.
P2860
Q34405616-9940A212-6CB9-4DBD-9BD1-C111037377E4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34405616-9940A212-6CB9-4DBD-9BD1-C111037377E4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9a54137a439e3e49a9519adf40bb806cf3089ea5
P2860
Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma